Literature DB >> 3559143

Early alcoholic liver injury. Activation of lipocytes in acinar zone 3 and correlation to degree of collagen formation in the Disse space.

T Horn, J Junge, P Christoffersen.   

Abstract

Acinar zone 3 areas in liver biopsy specimens from 23 alcoholics and 47 non-alcoholics were investigated by light microscopy and transmission electron microscopy to asses fibrosis in the perisinusoidal space and to evaluate the role of the lipocytes. Quantitative analysis by light microscopy on toluidine blue-stained sections showed a significant reduction in number of lipocytes--median values of 2.7 and 1.2 lipocytes per 100 hepatocytes in biopsies from chronic alcoholics showing no or varying degrees of zone 3 fibrosis, respectively, as compared to 3.6 lipocytes per 100 hepatocytes in non-alcoholic livers. By transmission electron microscopy, the reduction in number of lipocytes was related to a corresponding increase in number of cells rich in rough endoplasmic reticulum and microfilaments (activated lipocytes). The occurrence of activated cells was significantly correlated to fibrosis of the perisinusoidal space. Activation of lipocytes and collagenization of the perisinusoidal space appeared before light microscopic evidence of fibrosis and were topographically not related to Mallory bodies or alcoholic hepatitis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3559143     DOI: 10.1016/s0168-8278(86)80486-x

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  10 in total

1.  Role of A-Kinase Anchoring Protein Phosphorylation in Alcohol-Induced Liver Injury and Hepatic Stellate Cell Activation.

Authors:  Komal Ramani; Maria Lauda Tomasi; Joshua Berlind; Nirmala Mavila; Zhaoli Sun
Journal:  Am J Pathol       Date:  2018-01-02       Impact factor: 4.307

2.  Light microscopical demonstration and zonal distribution of parasinusoidal cells (Ito cells) in normal human liver.

Authors:  T Horn; J Junge; O Nielsen; P Christoffersen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

Review 3.  The hepatic stellate (Ito) cell: its role in human liver disease.

Authors:  M L Hautekeete; A Geerts
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

4.  Fat-storing cells and myofibroblasts are involved in the initial phase of carbon tetrachloride-induced hepatic fibrosis in BN/BiRij rats.

Authors:  W F Seifert; P J Roholl; B Blauw; F van der Ham; C F van Thiel-De Ruiter; I Seifert-Bock; A Bosma; D L Knook; A Brouwer
Journal:  Int J Exp Pathol       Date:  1994-04       Impact factor: 1.925

5.  Alcoholic liver disease. Parenchyma to stroma relationship in fibrosis and cirrhosis as revealed by three-dimensional reconstruction and immunohistochemistry.

Authors:  H P Dinges; K Zatloukal; H Denk; J Smolle; S Mair
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

6.  Alpha-smooth-muscle actin expression in normal and fibrotic human livers.

Authors:  K Yamaoka; T Nouchi; F Marumo; C Sato
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

Review 7.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

Review 8.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.

Authors:  A M Gressner; R Weiskirchen
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

Review 9.  The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injury.

Authors:  R Bruck; R Hershkoviz; O Lider; H Shirin; H Aeed; Z Halpern
Journal:  Yale J Biol Med       Date:  1997 Jul-Aug

10.  Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options.

Authors:  Olav A Gressner; Ralf Weiskirchen; Axel M Gressner
Journal:  Comp Hepatol       Date:  2007-07-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.